0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover273.14%IV-60.00%PremiumJan 17, 2025Expiry Date0.75Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8670Delta0.4762Gamma1.61Leverage Ratio-0.0072Theta-0.0003Rho-1.40Eff Leverage0.0004Vega
Rani Therapeutics Stock Discussion
Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
No comment yet